{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:58:46Z","timestamp":1793764726800,"version":"4.6.1"},"reference-count":68,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2014.00357","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T17:12:54Z","timestamp":1414602774000},"source":"Crossref","is-referenced-by-count":28,"title":["Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability"],"prefix":"10.3389","volume":"8","author":[{"given":"Thorsten R.","family":"Doeppner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.22-03-00629.2002","article-title":"Neurogenesis in adult subventricular zone","volume":"22","author":"Alvarez-Buylla","year":"2002","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nm747","article-title":"Neuronal replacement from endogenous precursors in the adult brain after stroke","volume":"8","author":"Arvidsson","year":"2002","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2007.06.012","article-title":"Neural stem\/precursor cells for the treatment of ischemic stroke","volume":"265","author":"Bacigaluppi","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/brain\/awp174","article-title":"Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms","volume":"132","author":"Bacigaluppi","year":"2009","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/VHRM.s25745","article-title":"The potential benefit of stem cell therapy after stroke: an update","volume":"8","author":"Banerjee","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"B7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2009.10.010","article-title":"Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection","volume":"221","author":"Barbosa da Fonseca","year":"2010","journal-title":"Exp. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/rme.10.97","article-title":"Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke","volume":"6","author":"Battistella","year":"2011","journal-title":"Regen. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovasc. Dis. Extra"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","article-title":"Stem cell therapy: a clinical trial of stroke","volume":"115","author":"Bhasin","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","article-title":"Optimizing the success of cell transplantation therapy for stroke","volume":"37","author":"Bliss","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.str.0000247888.25985.62","article-title":"Cell transplantation therapy for stroke","volume":"38","author":"Bliss","year":"2007","journal-title":"Stroke"},{"key":"B15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0065-230X(08)00005-5","article-title":"The tumorigenicity of human embryonic stem cells","volume":"100","author":"Blum","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.4161\/cc.8.23.10067","article-title":"The tumorigenicity of diploid and aneuploid human pluripotent stem cells","volume":"8","author":"Blum","year":"2009","journal-title":"Cell Cycle"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1242\/dev.104596","article-title":"Adult neurogenesis: mechanisms and functional significance","volume":"141","author":"Braun","year":"2014","journal-title":"Development"},{"key":"B18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.str.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1161\/STROKEAHA.111.627174","article-title":"Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"B21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.res.0000063425.51108.8d","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","journal-title":"Circ. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-1331.2012.03877.x","article-title":"Proximity of brain infarcts to regions of endogenous neurogenesis and involvement of striatum in ischaemic stroke","volume":"20","author":"Delavaran","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2008.12.013","article-title":"TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia","volume":"34","author":"Doeppner","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2010.05.033","article-title":"Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke","volume":"40","author":"Doeppner","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/stem.1098","article-title":"Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation","volume":"30","author":"Doeppner","year":"2012","journal-title":"Stem Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/SCCAA.s7820","article-title":"Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities","volume":"3","author":"Doeppner","year":"2010","journal-title":"Stem Cells Cloning"},{"key":"B27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0092-8674(00)80783-7","article-title":"Subventricular zone astrocytes are neural stem cells in the adult mammalian brain","volume":"97","author":"Doetsch","year":"1999","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1523\/JNEUROSCI.17-13-05046.1997","article-title":"Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain","volume":"17","author":"Doetsch","year":"1997","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00019052-200502000-00012","article-title":"Adult stem cell therapy in stroke","volume":"18","author":"Haas","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1474-4422(12)70039-X","article-title":"Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation","volume":"11","author":"Hermann","year":"2012","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.tcb.2014.07.003","article-title":"Adult neurogenesis: bridging the gap between mice and humans","volume":"24","author":"Jessberger","year":"2014","journal-title":"Trends Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J. Neurosurg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/wnl.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2009.12.001","article-title":"Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats","volume":"1315","author":"Kranz","year":"2010","journal-title":"Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","article-title":"Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model","volume":"11","author":"Kurozumi","year":"2005","journal-title":"Mol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1634\/stemcells.2007-1006","article-title":"Concise review: adult multipotent stromal cells and cancer: risk or benefit?","volume":"26","author":"Lazennec","year":"2008","journal-title":"Stem cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"B41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5966\/sctm.2011-0039","article-title":"Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms","volume":"1","author":"Leong","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1212\/wnl.59.4.514","article-title":"Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery","volume":"59","author":"Li","year":"2002","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1523\/JNEUROSCI.18-19-07768.1998","article-title":"Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils","volume":"18","author":"Liu","year":"1998","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbr.2013.10.030","article-title":"Human bone marrow mesenchymal stem\/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery","volume":"259","author":"Mitkari","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e43683","DOI":"10.1371\/journal.pone.0043683","article-title":"Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice","volume":"7","author":"Mora-Lee","year":"2012","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.jcbfm.9600527","article-title":"Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia","volume":"28","author":"Onda","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1073858403252680","article-title":"Injury-induced neurogenesis in the adult mammalian brain","volume":"9","author":"Parent","year":"2003","journal-title":"Neuroscientist"},{"key":"B49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10517-005-0229-y","article-title":"Cell therapy of brain stroke","volume":"139","author":"Rabinovich","year":"2005","journal-title":"Bull. Exp. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnins.2014.00053","article-title":"Vascular regulation of adult neurogenesis under physiological and pathological conditions","volume":"8","author":"Sawada","year":"2014","journal-title":"Front. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1161\/strokeaha.108.513978","article-title":"Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury","volume":"39","author":"Schwarting","year":"2008","journal-title":"Stroke"},{"key":"B55","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.nbd.2010.12.009","article-title":"Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5","volume":"41","author":"Sheikh","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","article-title":"Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke","volume":"27","author":"Shen","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.conb.2013.09.004","article-title":"Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration and aging","volume":"23","author":"Silva-Vargas","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ymthe.2004.02.012","article-title":"Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy","volume":"9","author":"Spees","year":"2004","journal-title":"Mol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neulet.2012.01.078","article-title":"Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia","volume":"513","author":"Steiner","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/RNN-2009-0483","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients","volume":"27","author":"Su\u00c3\u00a1rez-Monteagudo","year":"2009","journal-title":"Restor. Neurol. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/jnr.10378","article-title":"Adult neurogenesis and neural stem cells of the central nervous system in mammals","volume":"69","author":"Taupin","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/glia.10209","article-title":"Differential proliferative response in the postischemic hippocampus, temporal cortex and olfactory bulb of young adult macaque monkeys","volume":"42","author":"Tonchev","year":"2003","journal-title":"Glia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/neu.2006.0161","article-title":"Mesenchymal stem cells derived from peripheral blood protects against ischemia","volume":"24","author":"Ukai","year":"2007","journal-title":"J. Neurotrauma"},{"key":"B64","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1523\/jneurosci.0149-06.2006","article-title":"Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum","volume":"26","author":"Yamashita","year":"2006","journal-title":"J. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1161\/strokeaha.111.000821","article-title":"Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke","volume":"44","author":"Yang","year":"2013","journal-title":"Stroke"},{"key":"B66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3858\/emm.2008.40.4.387","article-title":"Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model","volume":"40","author":"Yoo","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1517\/14712598.2013.804507","article-title":"Cell-based therapy for ischemic stroke","volume":"13","author":"Zhang","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2009.11.012","article-title":"Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia","volume":"1310","author":"Zheng","year":"2010","journal-title":"Brain Res."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T19:51:10Z","timestamp":1565985070000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fncel.2014.00357\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":68,"URL":"https:\/\/doi.org\/10.3389\/fncel.2014.00357","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}